Статья

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era

W. Qin, F. Dong, Z. Zhang, B. Hu, S. Chen, Z. Zhu, F. Li, X. Wang, Y. Zhang, Y. Wang, K. Zhen, J. Wang, I. Elalamy, C. Li, Z. Zhai, B. Davidson, C. Wang,
2021

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • W. Qin
    Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jianghan University, No.168 Hongkong Road, Jiang'an District, Wuhan City, Hubei Province 430000, China
  • F. Dong
    Institute of Clinical Medical Sciences, China–Japan Friendship Hospital, Beijing, China
  • Z. Zhang
    Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, China
  • B. Hu
    Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, China
  • S. Chen
    National Clinical Research Center for Respiratory Diseases, China
  • Z. Zhu
    Institute of Basic Research, Chinese Academy of Medical Sciences, China
  • F. Li
    Hematology and Thrombosis Center, Tenon University Hospital, INSERM UMRS 938, Sorbonne University, Paris, France
  • X. Wang
    The First I.M. Sechenov Moscow State Medical University, Moscow, Russian Federation
  • Y. Zhang
    Division of Pulmonary and Critical Care Medicine, Providence Health System, Seattle, WA, United States
  • Y. Wang
    Peking Union Medical College, Chinese Academy of Medical Sciences, China
  • K. Zhen
  • J. Wang
  • I. Elalamy
  • C. Li
  • Z. Zhai
  • B. Davidson
  • C. Wang
Название журнала
  • Thrombosis Research
Том
  • 198
Страницы
  • 19-22
Ключевые слова
  • amoxicillin; aspartate aminotransferase; azithromycin; C reactive protein; cefamandole; ceftazidime; ceftriaxone; corticosteroid; creatinine; D dimer; fibrinogen; globulin; levofloxacin; low molecular weight heparin; methylprednisolone; piperacillin; procalcitonin; sulbactam; anticoagulant agent; low molecular weight heparin; activated partial thromboplastin time; adult; adult respiratory distress syndrome; aged; anticoagulant therapy; anticoagulation; cohort analysis; controlled study; coronavirus disease 2019; disease severity; drug use; epidemic; female; fibrinogen blood level; gastrointestinal hemorrhage; hospital admission; human; human cell; incidence; invasive ventilation; Letter; leukocyte count; lymphocyte count; major clinical study; male; middle aged; mortality; mortality risk; noninvasive ventilation; observational study; oxygen therapy; priority journal; prophylaxis; prothrombin time; Sequential Organ Failure Assessment Score; sex difference; survival; bleeding; blood; China; drug therapy; epidemiology; hospital mortality; hospitalization; mortality; risk factor; time factor; treatment outcome; very elderly; Adult; Aged; Aged, 80 and over; Anticoagulants; China; COVID-19; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Risk Factors; Time Factors; Treatment Outcome
Издатель
  • Elsevier Ltd
Тип документа
  • Letter
Тип лицензии Creative Commons
  • CC BY-NC-ND
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus